Global DNA Fragment Service Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global DNA Fragment Service market size will reach US$ 3918 million by 2031.
DNA Fragment Service is a specialized biotechnology offering that provides the custom synthesis of specific DNA sequences through chemical synthesis or enzymatic assembly. It is widely used in applications such as molecular cloning, gene editing, vaccine development, synthetic biology, and protein expression. Based on customer-supplied sequences, the service can generate single- or double-stranded DNA fragments ranging from a few dozen to several thousand base pairs, with options to incorporate features such as restriction sites, tags, promoters, or other functional elements. Compared to traditional PCR-based methods, synthetic DNA fragments offer higher sequence accuracy, greater design flexibility, and faster turnaround, significantly improving experimental efficiency. High-quality DNA synthesis services typically include sequence verification (e.g., Sanger sequencing), purification, and quality control reports to ensure reliability and reproducibility. This service provides a foundational tool for modern life sciences research and industrial biotechnology innovation.
United States market for DNA Fragment Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for DNA Fragment Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for DNA Fragment Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key DNA Fragment Service players cover CD Genomics, GenScript, Eurofins Scientific, Base Gene, Tsingke, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “DNA Fragment Service Industry Forecast” looks at past sales and reviews total world DNA Fragment Service sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Fragment Service sales for 2025 through 2031. With DNA Fragment Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Fragment Service industry.
This Insight Report provides a comprehensive analysis of the global DNA Fragment Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on DNA Fragment Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Fragment Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Fragment Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Fragment Service.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Fragment Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
DNA Short Fragment Service
DNA Long Fragment Service
Segmentation by Application:
Molecular Cloning
Gene Editing
Vaccine Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD Genomics
GenScript
Eurofins Scientific
Base Gene
Tsingke
Geneviz
IDT
MCLAB
Synbio Technologies
NZYtech
Genetika Science Indonesia
Bio Basic
GenCefe
Please note: The report will take approximately 2 business days to prepare and deliver.
DNA Fragment Service is a specialized biotechnology offering that provides the custom synthesis of specific DNA sequences through chemical synthesis or enzymatic assembly. It is widely used in applications such as molecular cloning, gene editing, vaccine development, synthetic biology, and protein expression. Based on customer-supplied sequences, the service can generate single- or double-stranded DNA fragments ranging from a few dozen to several thousand base pairs, with options to incorporate features such as restriction sites, tags, promoters, or other functional elements. Compared to traditional PCR-based methods, synthetic DNA fragments offer higher sequence accuracy, greater design flexibility, and faster turnaround, significantly improving experimental efficiency. High-quality DNA synthesis services typically include sequence verification (e.g., Sanger sequencing), purification, and quality control reports to ensure reliability and reproducibility. This service provides a foundational tool for modern life sciences research and industrial biotechnology innovation.
United States market for DNA Fragment Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for DNA Fragment Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for DNA Fragment Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key DNA Fragment Service players cover CD Genomics, GenScript, Eurofins Scientific, Base Gene, Tsingke, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “DNA Fragment Service Industry Forecast” looks at past sales and reviews total world DNA Fragment Service sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Fragment Service sales for 2025 through 2031. With DNA Fragment Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Fragment Service industry.
This Insight Report provides a comprehensive analysis of the global DNA Fragment Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on DNA Fragment Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Fragment Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Fragment Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Fragment Service.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Fragment Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
DNA Short Fragment Service
DNA Long Fragment Service
Segmentation by Application:
Molecular Cloning
Gene Editing
Vaccine Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD Genomics
GenScript
Eurofins Scientific
Base Gene
Tsingke
Geneviz
IDT
MCLAB
Synbio Technologies
NZYtech
Genetika Science Indonesia
Bio Basic
GenCefe
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
108 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 DNA Fragment Service Market Size by Player
- 4 DNA Fragment Service by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global DNA Fragment Service Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
